Horizon Therapeutics PLC (NASDAQ:HZNP)

70.52
Delayed Data
As of Nov 27
 +1.62 / +2.35%
Today’s Change
23.81
Today|||52-Week Range
86.67
+94.81%
Year-to-Date
HorizonTherapeutics (HZNP) Rises YTD on Approvals & Buyouts
Nov 27 / Zacks.com - Paid Partner Content
John Paulson Buys Lear, Sells TD Ameritrade
Nov 23 / GuruFocus News - Paid Partner Content
Horizon (HZNP) and Halozyme Ink Deal for ENHANZE Technology
Nov 24 / Zacks.com - Paid Partner Content
Is Horizon Therapeutics (HZNP) a Worthy Stock Now?
Nov 20 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close68.90
Today’s open69.95
Day’s range69.90 - 70.95
Volume114,583
Average volume (3 months)2,343,853
Market cap$15.5B
Data as of 12:59pm ET, 11/27/2020

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+85.91%
Earnings growth (next 5 years)+30.12%
Revenue growth (last year)+7.66%
P/E ratio17.8
Price/Sales5.71
Price/Book6.04

Competitors

 Today’s
change
Today’s
% change
CTLTCatalent Inc+2.62+2.77%
ALNYAlnylam Pharmaceutic...+4.40+3.51%
INCYIncyte Corp+2.16+2.66%
----
Data as of 1:00pm ET, 11/27/2020

Financials

Next reporting dateMarch 3, 2021
EPS forecast (this quarter)$1.02
Annual revenue (last year)$1.3B
Annual profit (last year)$573.0M
Net profit margin44.08%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
No executives to display
Corporate headquarters
Dublin, Dublin

Forecasts